Predictive Oncology Stock Price on June 26, 2024
| POAI Stock | USD 1.04 0.02 1.89% |
Below is the normalized historical share price chart for Predictive Oncology extending back to April 09, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Predictive Oncology stands at 1.04, as last reported on the 29th of June, with the highest price reaching 1.11 and the lowest price hitting 1.02 during the day.
If you're considering investing in Predictive Stock, it is important to understand the factors that can impact its price. Predictive Oncology maintains Sharpe Ratio (i.e., Efficiency) of -0.0977, which implies the firm had a -0.0977% return per unit of risk over the last 3 months. Predictive Oncology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Predictive Oncology's Coefficient Of Variation of (834.57), variance of 77.28, and Risk Adjusted Performance of (0.07) to confirm the risk estimate we provide.
As of now, Predictive Oncology's Common Stock Total Equity is decreasing as compared to previous years. The Predictive Oncology's current Common Stock Shares Outstanding is estimated to increase to about 4.2 M, while Total Stockholder Equity is projected to decrease to under 5 M. . The Predictive Oncology's current Price Earnings To Growth Ratio is estimated to increase to 0.03, while Price To Sales Ratio is projected to decrease to 7.05. Predictive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of January 2018 | 200 Day MA 2.6297 | 50 Day MA 1.4537 | Beta 1.333 |
Predictive |
Sharpe Ratio = -0.0977
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | POAI |
Estimated Market Risk
| 8.84 actual daily | 78 78% of assets are less volatile |
Expected Return
| -0.86 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Predictive Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Predictive Oncology by adding Predictive Oncology to a well-diversified portfolio.
Price Book 0.8645 | Enterprise Value Ebitda (0.1) | Price Sales 4.017 | Shares Float 3.8 M | Wall Street Target Price 5 |
Related Headline
Microbot Medical Headline on 26th of June 2024
Transforming surgery Microbot Medical and Boston hospital co... by finance.yahoo.com
The alliance underscores the potential of robot technology into surgical practices and demonstrates a commitment to innovation.
Predictive Oncology Valuation on June 26, 2024
It is possible to determine the worth of Predictive Oncology on a given historical date. On June 26, 2024 Predictive was worth 1.04 at the beginning of the trading date compared to the closed value of 1.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Predictive Oncology stock. Still, in general, we apply an absolute valuation method to find Predictive Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Predictive Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Predictive Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 1.12 | 1.12 | 1.02 | 1.06 | 100,218 | |
06/26/2024 | 1.04 | 1.06 | 1.03 | 1.06 | 56,229 |
| 1.04 | 1.09 | 1.03 | 1.04 | 18,170 |
| Backtest Predictive Oncology | | | Predictive Oncology History | | | Predictive Oncology Valuation | Previous | Next |
Predictive Oncology Trading Date Momentum on June 26, 2024
| On June 27 2024 Predictive Oncology was traded for 1.04 at the closing time. The top price for the day was 1.09 and the lowest listed price was 1.03 . The trading volume for the day was 18.2 K. The trading history from June 27, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 1.89% . The trading delta at closing time against the current closing price is 1.89% . |
Predictive Oncology Fundamentals Correlations and Trends
By evaluating Predictive Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Predictive Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Predictive financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Predictive Oncology Stock history
Predictive Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Predictive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Predictive Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Predictive Oncology stock prices may prove useful in developing a viable investing in Predictive Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4 M | 4.2 M | |
| Net Loss | -23.2 M | -24.3 M |
Predictive Oncology Stock Technical Analysis
Predictive Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.